- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04515303
Digital Intervention Participation in DASH
Optimizing Inclusion of Blacks Within a Dietary Change Intervention to Reduce Hypertension
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
Nearly 50% of adults in the United States have high blood pressure, a leading contributor to cardiovascular disease. When race is considered, the majority of black adults (55%) have high blood pressure, a greater prevalence than other racial/ethnic groups. The elevated rate of high blood pressure, a diet-related disease, reflects the sub-optimal diet quality observed in blacks. The DASH dietary pattern is an evidence-based strategy to treat high blood pressure that has become part of the Dietary Guidelines for Americans. DASH promotes a diet rich in fruits and vegetables, low-fat dairy, controlled amounts of total fat, cholesterol and saturated fat, high fiber and protein content. Data from the National Health and Nutrition Examination Survey indicate that approximately 19% of adults with high blood pressure were DASH adherent. Those who were adherent tended to be older and non-black with a higher education level. Even after intervention, lower DASH adherence scores have been seen in blacks versus whites, possibly due to lower baseline consumption of DASH foods in blacks. Although dietary improvements from DASH-promoting interventions have been observed, adherence has decreased over time, and when translated to less controlled settings. Sufficient representation of blacks is important for clinical trials testing DASH given the disproportionate prevalence of high blood pressure. This study will examine factors that may influence black adults' participation and success in improving dietary quality through the following aims:
- To identify barriers to and facilitators of recruiting black adults into a digital DASH-promoting intervention. A semi-structured interview guide will direct individual interviews via phone with black men and women to understand what supports or deters participation in a digital health intervention trial for dietary quality improvement.
To determine the barriers and facilitators to improving dietary quality in black adults.
Participants in the individual interviews (Aim 1) will also identify their motivations, concerns and priorities surrounding dietary change. This will inform recruitment efforts and our understanding about how to improve dietary quality.
- To conduct secondary data analyses to determine the effectiveness, by race and gender group, of various recruitment methods from a 12-month randomized controlled trial to examine the effects of the intervention on changes in dietary quality and blood pressure among men and women with high blood pressure (clinical trails identifier: NCT03875768). The intervention asks participants to track their diet daily using a common commercial tracking app with an extensive nutrient database via smartphone. Food and nutrient data from the app is processed using an application programming interface, compared against an algorithm, and generates personalized automated text messages to each participant with information on DASH diet adherence and diet tips. Responsive coaching is also included for participants that require greater support for dietary change.
Diverse sample recruitment is essential to producing outcomes that are applicable to diverse populations living with hypertension. Examination of barriers and facilitators to consuming a quality diet and identification of effective recruitment methods for digital interventions may inform how investigators reach black men and women with hypertension to effectively improve diet for the treatment of cardiovascular disease.
Studientyp
Einschreibung (Voraussichtlich)
Kontakte und Standorte
Studienkontakt
- Name: Loneke Blackman Carr, PhD, RD
- Telefonnummer: 860-486-5073
- E-Mail: Loneke.blackman_carr@uconn.edu
Studienorte
-
-
Connecticut
-
Storrs, Connecticut, Vereinigte Staaten, 06103
- Rekrutierung
- University of Connecticut
-
Kontakt:
- Loneke T. Blackman Carr, PhD, RD
- Telefonnummer: 860-486-5073
- E-Mail: loneke.blackman_carr@uconn.edu
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- self-identify as having high blood pressure
- self-identify as Black/African American/Afro-Caribbean
- at least 18 years old
- self-reported body mass index≥ 18.5 kg/m2
- email address
- English is primary language
Exclusion Criteria:
- planning to leave the area during study time period
- participating in a related trial
- cardiovascular disease event (e.g. stroke, myocardial infarction) in prior 6 months
- pregnancy - current or planned during the study period
- active malignancy
- recent psychiatric institutionalization
- documented dementia
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Barriers and facilitators of recruitment
Zeitfenster: day 1
|
Using individual interviews to elicit information of potential recruitment preferences
|
day 1
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Barriers and facilitators of diet quality
Zeitfenster: day 1
|
Individual interviews to understand black men/women's diet quality experiences
|
day 1
|
|
Comparison of recruitment methods
Zeitfenster: Baseline
|
Use recruitment data collected from the main trial to compare the most effective recruitment methods for black men and women
|
Baseline
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Loneke Blackman Carr, PhD, RD, University of Connecticut
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- KFS 5658780
- 3R01HL146768-01S1 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Diverse Intervention Participation in DASH
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RekrutierungHypertonie | Typ-2-Diabetes mellitus (T2DM)Vereinigte Staaten
-
Kaiser PermanenteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); LifeWorks... und andere MitarbeiterAbgeschlossenReduzierung des Gewichts- und Diabetesrisikos in einer unterversorgten Bevölkerung (STRIDE) (STRIDE)Psychotische Störungen | Diabetes mellitus, Typ 2 | GewichtsverlustVereinigte Staaten
-
Shiraz University of Medical SciencesAbgeschlossenFettleibigkeitIran, Islamische Republik
-
Hospital de Clinicas de Porto AlegreBeendetBlutdruckBrasilien
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...AbgeschlossenHypertonieVereinigte Staaten
-
Purdue UniversityUniversity of Oregon; University of Missouri-Columbia; University of Virginia; Indiana... und andere MitarbeiterRekrutierungEltern | BetreuerVereinigte Staaten
-
Oregon Health and Science UniversityKaiser PermanenteAbgeschlossenFettleibigkeit